Alpha-Lipoic Acid Clinical Trials

• Painful HIV Neuropathy and Alpha-Lipoic Acid
  ClinicalTrials.gov Identifier: NCT00079807 - Active, not recruiting
  HIV; Peripheral Neuropathy
  
• Alpha Lipoic Acid and Polycystic Ovary Syndrome
  ClinicalTrials.gov Identifier: NCT00505427 - Recruiting
  Insulin Resistance; Oxidative Stress
  
• Provision of Antioxidant Therapy in Hemodialysis (PATH) Study
  ClinicalTrials.gov Identifier: NCT00237718 - Recruiting
  End Stage Renal Disease
  
• Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
  ClinicalTrials.gov Identifier: NCT00477607 - Recruiting
  Ototoxicity; Unspecified Adult Solid Tumor, Protocol Specific
  
• Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
  ClinicalTrials.gov Identifier: NCT00570596 - Recruiting
  Ototoxicity; Unspecified Adult Solid Tumor, Protocol Specific
  
• Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00187564 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Immune Restoration by Lipoic Acid in AIDS
  ClinicalTrials.gov Identifier: NCT00033176 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infections
  
• Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)
  ClinicalTrials.gov Identifier: NCT00308971 - Active, not recruiting
  Chronic Kidney Disease
  
• Anti-Oxidant Treatment of Alzheimer''s Disease
  ClinicalTrials.gov Identifier: NCT00117403 - Active, not recruiting
  Alzheimer''s Disease
  
• An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00116207 - Recruiting
  Diabetic Autonomic Neuropathy
  
• Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00090402 - Completed
  Alzheimer's Disease; Oxidative Stress; Dementia; Hyperlipidemia; Inflammation
  
• CVD Risk and Prevention in Early Glucose Intolerance
  ClinicalTrials.gov Identifier: NCT00122447 - Recruiting
  Impaired Glucose Tolerance (IGT)
  
• Antioxidant Functions of Lipoic Acid
  ClinicalTrials.gov Identifier: NCT00065624 - Completed
  Hypercholesterolemia
  
• Alpha Lipoic Acid for Burning Mouth
  ClinicalTrials.gov Identifier: NCT00387543 - Completed
  Burning Sore Mouth
  
• Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00490867 - Active, not recruiting
  Type 2 Diabetes
  
• Natural Antioxidants in the Treatment of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00010842 - Completed
  Multiple Sclerosis
  
• The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00398892 - Not yet recruiting
  Diabetes Mellitus, Type 2
  
• 4-PBA: Will it increase the level of Alpha 1-Antitrypsin(AAT) in persons with AAT deficiency?
  ClinicalTrials.gov Identifier: NCT00067756 - Active, not recruiting
  alpha 1-Antitrypsin Deficiency
  
• Genetics of Alpha Thalassemia in Israeli Ethnic Groups
  ClinicalTrials.gov Identifier: NCT00159029 - Recruiting
  alpha Thalassemia
  
• Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
  ClinicalTrials.gov Identifier: NCT00226408 - Recruiting
  Adjuvant; Stage III Malignant Melanoma; Interferon Alpha; Therapy
  
• Alpha-1 Coded Testing Study (ACT Trial)
  ClinicalTrials.gov Identifier: NCT00500123 - Recruiting
  Alpha 1-Antitrypsin Deficiency
  
• Alpha-1 Foundation Research Registry
  ClinicalTrials.gov Identifier: NCT00499941 - Recruiting
  Alpha 1-Antitrypsin Deficiency
  
• Efficacy and Safety Study of Augmentation Therapy With Aralast (Human Alpha 1 - Proteinase Inhibitor)
  ClinicalTrials.gov Identifier: NCT00396006 - Recruiting
  Alpha 1-Antitrypsin Deficiency
  
• Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency
  ClinicalTrials.gov Identifier: NCT00377416 - Active, not recruiting
  Alpha 1-Antitrypsin Deficiency
  
• ABR-217620 With Interferon-Alpha (IFN-Alpha) Compared to IFN-Alpha Alone in Patients With Advanced Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00420888 - Recruiting
  Renal Cell Carcinoma
  
• Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease
  ClinicalTrials.gov Identifier: NCT00025896 - Completed
  Pompe Disease; Glycogen Storage Disease Type II; Acid Maltase Deficiency Disease; Glycogenosis 2
  
• Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation
  ClinicalTrials.gov Identifier: NCT00502021 - Not yet recruiting
  Morbid Obesity; Atherosclerosis; Systemic Inflammation
  
• Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency
  ClinicalTrials.gov Identifier: NCT00430768 - Recruiting
  Alpha 1-Antitrypsin Deficiency
  
• The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency
  ClinicalTrials.gov Identifier: NCT00532805 - Recruiting
  Alpha-1 Antitrypsin Deficiency
  
• Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo
  ClinicalTrials.gov Identifier: NCT00342303 - Active, not recruiting
  Fatty Acid Metabolism
  
• A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
  ClinicalTrials.gov Identifier: NCT00099177 - Active, not recruiting
  Pain; Bone Neoplasms; Neoplasm Metastasis
  
• The Natural History of Alpha-Mannosidosis
  ClinicalTrials.gov Identifier: NCT00498420 - Recruiting
  Alpha Mannosidosis
  
• A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with intravenous ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
  ClinicalTrials.gov Identifier: NCT00099203 - Active, not recruiting
  Pain; Bone Neoplasms; Neoplasm Metastasis
  
• Relationship Between Folic Acid and Warfarin Metabolism and Effect
  ClinicalTrials.gov Identifier: NCT00162409 - Recruiting
  Folic Acid Deficiency
  
• Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00005665 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Interferon-Alpha for Diabetes Mellitus Type 1
  ClinicalTrials.gov Identifier: NCT00024518 - Active, not recruiting
  Insulin-Dependent Diabetes Mellitus
  
• DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00440050 - Active, not recruiting
  Alzheimer's Disease
  
• Double-Blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)
  ClinicalTrials.gov Identifier: NCT00145327 - Active, not recruiting
  Osteoporosis
  
• Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
  ClinicalTrials.gov Identifier: NCT00480207 - Recruiting
  Depression
  
• Therapy of Early Chronic Phase Chronic Myelogenous Leukemia with Gleevec, Alpha Interferon, and Ara-C
  ClinicalTrials.gov Identifier: NCT00048672 - Active, not recruiting
  Leukemia, Myeloid, Chronic-Phase
  
• On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
  ClinicalTrials.gov Identifier: NCT00161096 - Active, not recruiting
  Chronic Use of Acid Suppressive Medication; GORD; GERD; Reflux; Peptic Ulcer
  
• Efficacy of Prazosin Versus Placebo Associated with Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C with Genotype 1 or 4 and Severe Fibrosis
  ClinicalTrials.gov Identifier: NCT00148837 - Active, not recruiting
  Hepatitis C, Chronic; Fibrosis
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00045006 - Active, not recruiting
  Cancer
  
• Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) with Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
  ClinicalTrials.gov Identifier: NCT00038649 - Active, not recruiting
  Myelogenous Leukemia, Chronic, Chronic Phase
  
• Long-term Peginterferon alpha-2a Plus Ribavirin to Treat Chronic Hepatitis C in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00076765 - Recruiting
  Hepatitis C; HIV Infections
  
• Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
  ClinicalTrials.gov Identifier: NCT00157092 - Completed
  alpha 1-Antitrypsin Deficiency
  
• Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
  ClinicalTrials.gov Identifier: NCT00000621 - Active, not recruiting
  Emphysema; Lung Diseases; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency
  ClinicalTrials.gov Identifier: NCT00460096 - Completed
  Alpha 1-Antitrypsin Deficiency
  
• Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
  ClinicalTrials.gov Identifier: NCT00014027 - Recruiting
  Healthy
  
• Efficacy and Safety of Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women with Osteopenia, 45 Years of Age and Older.
  ClinicalTrials.gov Identifier: NCT00132808 - Active, not recruiting
  Osteopenia (osteoporosis prevention)
  
• Randomized Phase Iii-Study On Valproic Acid In Combination With All-Trans Retinoic Acid, Standard Induction- And Consolidation Therapy In Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151255 - Recruiting
  Acute myeloid leukemia, age > 60 years
  
• Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
  ClinicalTrials.gov Identifier: NCT00542347 - Recruiting
  Gastric Acid
  
• Aralast alpha1-Proteinase Inhibitor Surveillance Study
  ClinicalTrials.gov Identifier: NCT00313144 - Active, not recruiting
  Alpha 1-Antitrypsin Deficiency
  
• The Effect of Folic Acid on Efficacy of Sulfadoxine-Pyrimethamine in Pregnant Women in Western Kenya
  ClinicalTrials.gov Identifier: NCT00130065 - Active, not recruiting
  Malaria
  
• Randomized Phase Ii-Study On Valproic Acid, All-Trans Retinoic Acid And Their Combination In Induction And Consolidation Therapy As Well As Pegfilgrastim After Consolidation Therapy In Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151242 - Recruiting
  Acute Myeloid Leukemia
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00127127 - Active, not recruiting
  Tumors
  
• Controlled Trial of 4-Aminosalicylic Acid in Patients with Small Bowel Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00004423 - Active, not recruiting
  Crohn's Disease
  
• Study of Docosahexaenoic Acid (DHA) Supplementation in Patients with X-Linked Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00004827 - Active, not recruiting
  Retinitis Pigmentosa
  
• Beta-Carotene and Alpha-Tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
  ClinicalTrials.gov Identifier: NCT00169845 - Active, not recruiting
  Neoplasms
  
• An Investigational Drug Study with Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00097929 - Active, not recruiting
  B-Cell Lymphoma
  
• Peginterferon alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00018031 - Recruiting
  Hepatitis C; HIV Infections
  
• The Safety and Tolerability of Alpha-1 MP in Subjects With Alpha-1-Antitrypsin (AAT) Deficiency.
  ClinicalTrials.gov Identifier: NCT00301366 - Completed
  Alpha 1-Antitrypsin Deficiency
  
• Safety and Efficacy Trial with Zoledronic Acid for the Treatment of Paget's Disease of Bone
  ClinicalTrials.gov Identifier: NCT00103740 - Active, not recruiting
  Paget's Disease of Bone
  
• Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial
  ClinicalTrials.gov Identifier: NCT00522262 - Active, not recruiting
  Breast Neoplasms
  
• Pegylated Interferon-Alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB
  ClinicalTrials.gov Identifier: NCT00204529 - Active, not recruiting
  Melanoma
  
• Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects with Alpha 1-Antitrypsin Deficiency
  ClinicalTrials.gov Identifier: NCT00161707 - Completed
  alpha 1-Antitrypsin Deficiency
  
• Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
  ClinicalTrials.gov Identifier: NCT00004410 - Recruiting
  Cholestasis
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Malignant Lymphoma
  ClinicalTrials.gov Identifier: NCT00127140 - Active, not recruiting
  Malignant Lymphoma
  
• PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
  ClinicalTrials.gov Identifier: NCT00303290 - Active, not recruiting
  Chronic Myeloid Leukemia
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Relapsed Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00124631 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002650 - Active, not recruiting
  Rectal Cancer; prevention of colorectal cancer; Colon Cancer
  
• Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment
  ClinicalTrials.gov Identifier: NCT00558532 - Recruiting
  Morbid Obesity; Cardiovascular Disease; Fatty Acid Levels
  
• Suberoylanilide Hydroxamic Acid and Capecitabine in Treating Patients with Metastatic Or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00121277 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• The Role of Vitamins E and C in Maintaining Lung Health in People with Asthma
  ClinicalTrials.gov Identifier: NCT00142610 - Active, not recruiting
  Asthma
  
• Valproic Acid in Treating Patients With Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00075777 - Active, not recruiting
  recurrent Kaposi's sarcoma; epidemic Kaposi's sarcoma
  
• Lactic Acid in the Rectum and Life-Threatening Infection.
  ClinicalTrials.gov Identifier: NCT00197938 - Recruiting
  Septic Shock
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00005634 - Active, not recruiting
  Leukemia; Lymphoma; Prostate Cancer; Multiple Myeloma; Eye Cancer
  
• Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.
  ClinicalTrials.gov Identifier: NCT00502034 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer
  ClinicalTrials.gov Identifier: NCT00445523 - Active, not recruiting
  Carcinoma, Renal Cell
  
• A study of the safety and pharmacokinetics of rhGAA in siblings with Glycogen Storage Disease Type II
  ClinicalTrials.gov Identifier: NCT00051935 - Completed
  Glycogen Storage Disease Type II; Pompe Disease; Acid Maltase Deficiency Disease; Glycogenosis 2
  
• Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
  ClinicalTrials.gov Identifier: NCT00342992 - Active, not recruiting
  Lung Cancer; Prostatic Neoplasms; Prostate Cancer; Pancreatic Cancer
  
• Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003697 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• 48 Weeks Combination Therapy for Patients with HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
  ClinicalTrials.gov Identifier: NCT00114361 - Active, not recruiting
  Hepatitis B
  
• Pilot Study to Evaluate Nucleic Acid Amplification Methods in the Diagnosis and Management of Active TB
  ClinicalTrials.gov Identifier: NCT00023439 - Recruiting
  Tuberculosis
  
• Study to Evaluate Viral Kinetics in the First 12 Weeks of Patients With Hepatitis C Coinfected With HIV Treated With Induction Doses of Peginterferon Alpha-2a (40 KD) and Ribavirin With Epoetin β Support
  ClinicalTrials.gov Identifier: NCT00356486 - Active, not recruiting
  HIV Infections
  
• The Role of 5-Alpha Reductase in Mediating Testosterone Actions
  ClinicalTrials.gov Identifier: NCT00493987 - Recruiting
  Healthy
  
• Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
  ClinicalTrials.gov Identifier: NCT00004307 - Recruiting
  Amino Acid Metabolism, Inborn Errors
  
• Study of Zoledronic Acid for Patients With Hormone-Sensitive Bone Metastases From Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00242567 - Recruiting
  Prostate Cancer
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00132067 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00263484 - Recruiting
  Multiple Myeloma
  
• Ursodesoxycholic Acid in the Treatment of Duodenal Adenomas in FAP Patients.
  ClinicalTrials.gov Identifier: NCT00134758 - Recruiting
  Adenomatous Polyposis Coli; Adenoma
  
• Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year
  ClinicalTrials.gov Identifier: NCT00424983 - Recruiting
  Multiple Myeloma; Breast Cancer
  
• Clinical and Laboratory Study of Methylmalonic Acidemia
  ClinicalTrials.gov Identifier: NCT00078078 - Recruiting
  Amino Acid Metabolism; Inborn Errors
  
• Investigating the Role of Norepinephrine in Emotional Processing through Alpha-2 Adrenergic Receptor Modulation
  ClinicalTrials.gov Identifier: NCT00109642 - Recruiting
  
  
• Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients with Acute Renal Failure
  ClinicalTrials.gov Identifier: NCT00004496 - Recruiting
  Acute Renal Failure
  
• Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux
  ClinicalTrials.gov Identifier: NCT00231881 - Recruiting
  Gastro-Oesophageal Reflux
  
• Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
  ClinicalTrials.gov Identifier: NCT00410566 - Recruiting
  Acid Sphingomyelinase Deficiency; Niemann-Pick Disease
  
• Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024310 - Active, not recruiting
  Drug Toxicity; unspecified adult solid tumor, protocol specific
  
• Total Therapy II
  ClinicalTrials.gov Identifier: NCT00083551 - Active, not recruiting
  Multiple Myeloma
  
• Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
  ClinicalTrials.gov Identifier: NCT00199732 - Active, not recruiting
  Chronic Hepatitis B